Study of complement activity in microangiopathy affecting kidneys
Part of Blood & lymphatic, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at signs of a clotting problem in tiny blood vessels (called TMA) that can affect kidney function. The goal is to better understand the role of the body’s complement system and how it relates to different causes of this illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have acute kidney injury with an estimated GFR under 45
- You have confirmed TMA either by blood tests showing signs of hemolysis and low platelets, or by kidney biopsy
- Your TMA is from a complement-related cause such as atypical HUS, hypertensive emergency, pregnancy/postpartum, kidney donor recipient, or certain autoimmune diseases
- You can understand the study, sign consent, and follow study visits/tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies patients who have had a stem cell or solid organ transplant and may have a condition called TMA (small blood clots in vessels) or a viral infection. It aims to understand how certain immune system parts (complement and interferon) affect these conditions.
This trial tests a new drug, TGD001, for a condition called thrombotic microangiopathy (TMA), where small blood clots form in blood vessels and damage organs. The drug aims to break up clots and improve blood flow.
This trial looks for proteins in the blood that could help detect transplant-related blood vessel damage (called TMA) earlier, so doctors can treat it faster. It involves patients who have had a stem cell transplant from a donor.
This study looks back at medical records of people with immune-mediated thrombotic thrombocytopenic purpura (TTP), a rare blood clotting disorder. It aims to better understand the disease and how it is treated.
This trial builds a database to study patterns in blood tests and blood smear findings that can suggest small blood clots in the body. Joining may help researchers learn how to recognize and track these changes over time.
This study looks at people who have a blood clotting problem called TMA after a stem cell transplant from a donor. It gathers information from routine checkups to learn more about this condition.
Hear when a new Thrombotic Microangiopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.